The effect of magnesium citrate in asthma

Investigation of oral magnesium citrate compared to placebo on spirometry findings in patients with allergic asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017021032485N1

Enrollment

Registered

2017-02-24

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Asthma

Interventions

Intervention 1: Magnesium group: 300 mg magnesium citrate once a day for 2 months. Intervention 2: Placebo group: 300 mg starch once a day for 2 months.

Treatment - Drugs

Placebo

Magnesium group: 300 mg magnesium citrate once a day for 2 months

Placebo group: 300 mg starch once a day for 2 months

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age of 18-55 years; having moderate asthma. Exclusion criteria: having cardiac; renal disease; diabetes; other pulmonary diseases; uncontrolled hypertension.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Spirometry findings. Timepoint: At the end of the second month. Method of measurement: By spirometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Khammari

Zahedan University of Medical Sciences

Dr.khammari@zaums.ac.ir; Dr.khammari@gmail.com; ayubabedi48@gmail.com+98 54 3322 5715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026